Global Technical AssistanceProviding Expertise Where It’s Needed Most
Global Technical Assistance
With more than 17 years of experience providing impactful and sustainable technical assistance, capacity building and implementation support to ministries of health and other stakeholders in more than 30 PEPFAR-supported countries, ICAP’s teams of global and local experts combine forces to deliver the state-of-the-art approaches to tacking complex HIV service development, scale-up, and quality issues around the world.
Starting in 2002, ICAP’s global technical support work began through the University Technical Assistance Project (UTAP and UTAP-2) with funding from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). This project provided technical and administrative assistance to the national HIV responses in Cote d’Ivoire, Democratic Republic of Congo, Eswatini, Mozambique, Rwanda, South Africa, Tanzania, and Zambia. The UTAP-2 project was further extended to help the U.S. Centers for Disease Control and Prevention (CDC) conduct HIV surveillance training more efficiently through distance education. For access to the project reports, click here.
Furthering ICAP’s commitment to providing technical assistance, the Multicountry Columbia Antiretroviral Program (MCAP) was implemented from 2004-2012, This project rapidly expanded HIV programs by promoting early diagnosis of HIV infection, maintaining the health of people living with HIV, and preventing further transmission of HIV in the community in Kenya, Mozambique, Rwanda, South Africa, Tanzania, Cote D’Ivoire, Ethiopia, and Nigeria. To read the MCAP project reports, click here.
From 2014-2020, ICAP implemented the Global Technical Assistance project – an ambitious, six-year project spanning across 24 PEPFAR and Global Fund-supported countries. Working closely with CDC, ICAP leveraged its experience as a capacity-building innovator to provide technical expertise across the spectrum of HIV technical domains and service areas.
In 2020, ICAP is leading the five-year Programmatic Support Award (PSA) which is designed to provide comprehensive and cost-effective technical support that accelerates evidence-based HIV prevention and treatment program implementation and strengthens health systems in countries supported by PEPFAR. With CDC as a key technical partner, PSA is designed to fast-track local capacity to meet national HIV, PEPFAR, and UNAIDS goals.
ICAP is also responding to rapidly changing efforts around COVID-19 across the world. As the pandemic evolves, ICAP is providing urgent and necessary support to our partners – including ministries of health, research organizations, large multilaterals, health care providers, and patients – in their responses to address the global health emergency and identify solutions to prevent new infections. For the latest updates on ICAP’s work on the COVID-19 response, click here.
General Global Technical Assistance Resources:
- Viral Load Toolkit (English, French, Portuguese, Swahili, Ukranian)
- Infant HIV Testing: Implementation Guide for Programme Managers
- Counseling Cards for Caregivers of HIV-Exposed Infants and other Orphans and Vulnerable Children
- Rapid Testing Quality Improvement Initiative (RTQII) Handbook (English)
- ICAP Pre-exposure Prophylaxis (PrEP) Package (English, Spanish, French, Portuguese)
- The Power of PrEP Video Series
The Programmatic Support Award (PSA)
The Programmatic Support Award (PSA) is designed to provide comprehensive and cost-effective technical support that accelerates evidence-based HIV prevention and treatment program implementation and strengthens health systems in countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Building on more than 15 years of partnership between ICAP and the U.S. Centers for Disease Control and Prevention (CDC), PSA is designed to fast-track local capacity to meet national, PEPFAR, and UNAIDS goals. Specific approaches include designing and implementing:
- Innovative, effective, and comprehensive capacity-building strategies that strengthen service delivery and human resources for health
- High-quality and evidence-based HIV prevention, care, and treatment services for all populations (including priority and hard-to-reach groups)
- Customized strategic information approaches that generate data-driven evidence to improve HIV policies and programs
The Global Technical Assistance Project (2014-2020)
The Global Technical Assistance (GTA) Project, funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), was an ambitious, six-year project comprising 62 individual projects across 24 PEPFAR and Global Fund-supported countries on four continents.
Working in close collaboration with CDC, ICAP leveraged its deep expertise and experience as a technical assistance and capacity-building innovator across the spectrum of HIV technical domains and service areas, including:
- Pediatric and adult HIV care and treatment
- HIV testing
- HIV prevention
- Health systems strengthening
- Human resources for health
- Strategic information and surveillance
ICAP provided responsive and cost-effective technical assistance to ministries of health, implementing partners, and other stakeholders in partner countries to close gaps in HIV service delivery, strengthen the health workforce, and support ministries of health to collect and use strategic information to inform national policies and programs that drive progress toward HIV epidemic control.
Read the end-of-project report here.
ICAP’s Global Technical Assistance Countries: Updated as of 2019.
Other (Non-Country Specific):
- Assisted in the development and adaptation of a curriculum on early child development for HIV-exposed and infected infants.
- Helped identify best practices and develop guidelines for transitioning women living with HIV from Prevention of Mother-to-Child Transmission (PMTCT) services to antiretroviral therapy (ART) services in the postnatal period.
- Assisted in the development of guidance documents, training materials, and implementation tools to assist country programs in adopting new optimal pediatric HIV medication formulations.